Sentences with phrase «now studying patients»

His team is now studying patients who have especially high risk of heart failure with preserved ejection fraction (HFpEF).

Not exact matches

We have now completed several health studies in partnership with the Geisinger Health System, which provides primary care to over 450,000 patients in Pennsylvania, including many residing in fracking areas.

Speaking of checkpoint inhibitor drugs... Merck's star cancer immunotherapy treatment Keytruda is facing some troubling clinical trial incidents which have now compelled the Food and Drug Administration (FDA) to halt three studies of the drug in multiple myeloma, a rare blood cancer, after a number of patient deaths.

«If we add machine learning, the field of study that allows computers to self - learn without specific programming to do so, to existing artificial intelligence (A.I.), the resulting machines will be better able to diagnose and heal patients than their human counterparts can now,» he notes.

Now, the firms are hoping that the completion of the study will show cardiovascular improvement in these patients, giving them a strong argument to present to reticent physicians.

«20 - 30 % of coeliac patients on a gluten free diet still have irritable bowel syndrome (IBS) symptoms», according to one study *, and the low FODMAP diet is now a recommended treatment.

They know that birthing at home or in a birth center with a trained midwife is a very safe option with lower rates of interventions and high patient satisfaction but now you no longer have to search and search for studies regarding homebirth which are often buried by cultural anecdotes and message boards.

PFC was one of the initial study sites for FDA approval of the Follistim Pen, an FSH medication delivery device that today has made fertility drug administration much easier and comfortable for patients and is now widely used for ovarian stimulation.

Fluge and Mella are now working on a multicenter study and monitoring their original patients as they receive booster treatments, to try and determine optimal treatments for CFIDS.

The study, published in the Journal of Anatomy, recommends that searching for these HDMPs should now be included in the study of patients with osteoarthritis.

Now, in a study published February 13 in Science Signaling, Lin's team discovered that a chemical compound that activates ATF6 also converts patient - derived stem cells into blood vessels.

A dozen human studies of MDMA, LSD, a powerful African drug called ibogaine and psilocybin, from so - called «magic mushrooms,» are now under way, testing the once - stigmatized drugs as treatments for not only PTSD, but also cluster headaches and addiction, as well as anxiety and depression in cancer patients.

In a study from the University of Pennsylvania School of Nursing (Penn Nursing), a new, simplified Braden QD Scale now describes combined immobility - related and MDPI risk in a broader, more diverse sample of pediatric patients typically cared for in acute care environments.

«It is exciting to have an expanded group of patients who are now eligible for this drug,» said Garon, whose clinical studies helped lead to today's FDA approval.

«We now hope to design larger clinical studies to treat patients» tumors harboring these novel genomic aberrations to further explore the precise extent of clinical benefit for patients with primary or advanced cholangiocarcinoma.»

In a study under way at USP's Neuroimaging Laboratory (LIM - 21), the researchers are now seeking to correlate the cognitive profile observed in the two groups of cocaine - dependent patients with decision - making and resting - state brain activity, using functional magnetic resonance imaging (fMRI).

Now a University of Colorado Cancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining this failure and offering a possible strategy for the use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established therapies, breast cancer cells may have been pushed past an important tipping point that offers retinoic acid resistance.

Nearly all of the patients described in the study have continued their rehabilitation, now exceeding two years of training, Nicolelis said.

«Data from this study serves as rationale to now include dogs with spontaneous cancers in the advancement and optimization of PMed for human patients,» according to the study, Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.

Now, a pilot study presented here 18 April at the Federation of Societies for Experimental Biology meeting has identified 10 proteins that can distinguish ALS patients from healthy individuals.

In a study published today [Jan 26, 2016] in the journal Emerging Infectious Diseases, the team documents a disease trajectory that started with nine positive patients and has now spread to more than 13,000 infected individuals in that country.

The researchers now plan to start a study in the EU in which patients will undergo SN mapping (lymphoscintigraphy) after injection of both types of radiotracers.

However, there is now a glimmer of hope for patients: Thanks to a newly tested substance, the pain can be reduced to a tolerable level, as indicated by the promising results of an international phase II study involving the Center of Dental Medicine at the University of Zurich.

The current study has now shown that the tests that are currently commonly used, viewed over a period of ten years, allow only imprecise prognoses and that patients with non-ischaemic heart failure are at just as much risk and need to be treated accordingly.

The study began with a collaboration among the two lead authors — Harrison Brand, PhD, a research fellow in Talkowski's lab, who sequenced and analyzed the genomes of patients with arhinia, and Natalie Shaw, MD, then with the MGH Reproductive Endocrine Unit and now at the National Institute for Environmental Health Science, who was investigating the lack of reproductive development in a few patients with arhinia.

In 2003 Pennebaker and statistician R. Sherlock Campbell, now at Yale University, used a statistical tool called latent semantic analysis (LSA) to study the diary entries of trauma patients from three earlier studies, looking for text characteristics that had changed in patients who were convalescing and met rarely with their physician.

However, in the largest study of its kind so far, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population.

The research team is now moving forward with studies on more patients.

Dr Grainger and his team are now working with other groups at The University of Manchester to carry out further studies on monocytes, particularly from patients with inflammatory conditions, and are focused on identifying situations where this gut information system may have gone wrong such as in inflammatory bowel diseases.

Now, through an unexpected observation and a meticulous study of patients seen at Brigham and Women's Hospital, BWH investigators have added a fourth cause to the list: a genetic rearrangement in the ALK gene, observed in three patients with peritoneal mesothelioma.

The National Cancer Institute is now funding a study to determine what specific characteristics led to that trial's success, comparing two sets of modified immune cells in patients.

He is now hoping to involve more bed - bound patients, including locked - in patients in the study.

While the studies addressed in the paper focused on patients taking opioids for non-cancer pain such as back pain and other musculoskeletal ailments, similar studies are now underway to examine the effect of naloxegol in patients with chronic cancer - related pain.

«After years of collaboration with some of the world's leading prostate cancer researchers and medical institutions who have studied the scientific and clinical benefits of phi, we are pleased that the test is now available to help physicians and patients with an elevated PSA test result, more accurately detect prostate cancer2,» said John Blackwood, senior vice president, Chemistry / Immunoassay Business Unit, Beckman Coulter Diagnostics.

Now Dr Gerald Burgess has described the study of an amnesia patient — who suffered memory loss after root - canal treatment at a dentist — in an academic article in the journal Neurocase.

Physicians now have robust data to help them counsel patients and make informed decisions regarding treatment options,» says study co-author Lloyd P. Aiello, M.D., Ph.D., Professor of Ophthalmology at Harvard Medical School, Director of Joslin's Beetham Eye Institute, co-head of Joslin's Section of Vascular Cell Biology, and founding chair of the DRCR Network.

For years now the gold standard for R&D in Alzheimer's disease has focused on generating convincing evidence that any new therapy being studied could slow the cognitive decline of patients and help preserve their ability to perform the kind of daily functions that can keep a patient independent for a longer period of time.

The researchers now want to conduct follow - up studies to optimise the use of IgEnio — currently patients have to have IgE antibodies removed from their blood for a morning approximately once a week during the pollen season — and to test its use for treating inflammatory skin diseases, in which IgE antibodies are also implicated.

This study, following real - life patients for up to ten years, shows now that these good effects do not diminish over time.

Further studies are now planned with biosimilar - treated patients to better assess the potentially different immune responses associated with biologics.

The research team are now waiting for more mature data from the study to see whether crizotinib also improves overall survival in this patient group.

Now a newly published study with a distinctive design, led by an MIT health care scholar, shows that increased spending on emergency care does, in fact, produce better outcomes for patients.

«Now you can think about collecting a patient's cells and studying how those cells respond to different therapies.

As a result, many of the studies published up to now describe only two or three patient stem cell lines,» says David Panchision, who oversees the NIMH's National Cooperative Reprogrammed Cell Research Group (NCRCRG) program, which supported this work.

«Now that we have shown that anemia affects a patient's recovery, further studies are needed to determine the best way to correct it.

Over the next few decades, Laron studied more than 60 patients with the disorder that now bears his name.

Previous studies have found a decrease in behavioural and psychiatric symptoms of dementia when patients are treated for pain, but this new study now shows, for the first time, a decrease in symptomatic drug use.

Herold hopes to report data in the near future on a study of an antibody called anti-CD3; he has tested it in newly diagnosed patients and is now trying it as a preventive.

«Once we've shown that this can safely be used in human patients with pulmonary hypertension — and we've got a clinical trial in progress right now — we'll be able to conduct studies of inhaled NO delivered in ambulatory settings, including patients» homes, to treat chronic pulmonary hypertension, right - sided heart failure and chronic obstructive pulmonary disease.»

Hillis» preliminary study of six patients continued to show language improvement two weeks and two months later, and a clinical trial funded by the U.S. National Institutes of Health is now underway.